Find the nearest office SOLUTIONS EXPERTISE RESOURCES CONTACT CAREERS ABOUT NEIGHBORHOOD VCLS INNOVATION CENTER VCLS SOLUTIONS PRODUCT EXPERTISE MICROBIOME PRODUCTS Product expertise MICROBIOME PRODUCTS A microbiome describes the collection of microbial life (microbiota) that inhabit a specific environment, and include microorganisms as diverse as bacteria, yeasts, fungi, archaea and viruses. In man, these organisms are resident primarily in the gastrointestinal tract, but also occur on the skin, genitals and in the lungs. Although the extent of the relationship between microbiome and human health is not fully known yet, our understanding improves of the role these microorganisms have in the development of pathologies such as obesity, gastro-intestinal diseases, depression and allergies, the possibility now exists to address these, and other, health challenges from a new perspective. This includes the development of new foodstuffs to maintain beneficial gut flora, as well as the development of new drugs that offer more targeted possibilities. Microbiome products are typically designated as prebiotics, probiotics or postbiotics, however, these are not regulatory product categories. Applicable status may vary depending on the product intended purpose (including target population, claims, etc.), composition, route of administration, Mode of Action. They can either be drugs, LBPs, biological medicinal products, functional foods, food/dietary supplements, devices, transplants or tissues & cells. Some are specific to microbiome products (e.g. FMT) while other also apply to other types of health products. Key challenges encompass: Identifying cause-effect relationships Being able to restore a “healthy” microbiome when such microbiome is not well characterized Navigating the moving and multiple potential applicable regulatory frameworks as no harmonized approach is in place Main considerations to keep in mind if you are developing a microbiome related product: Microbiome products can fall under several regulatory statuses, in both the food and medical arenas Their intended use, target population, presentation form, composition, mode of action and route of administration will be key in determining the corresponding status Both drug and food pathways and associated regulatory statuses present specific benefits and constraints and will be directly related to the complexity, costs and timelines of development, and to the further marketing opportunities. VCLS contributes to the development of products within a comprehensive range of regulatory statuses, including drugs, biologics, ATMP, medical devices, FSMPs, Food supplements , etc. We have a solid track of experience in various therapeutic fields including infectious diseases, inflammatory diseases, immunology (including allergies), metabolic disorders, oncology with common applications in the gastro-intestinal tract, skin and gut-brain axis. What VCLS can offer: Early product positioning & Strategical development planning Identification of eligible regulatory paths, within the food and therapeutic arenas, as well as in the cosmetic field Re-qualification risk assessment & Identification of critical product features Target Product Profile (TPP) definition Assessment of optimal positioning based on subsequent development needs and risks Regulatory activities implementation Definition of optimal regulatory roadmap for international market entry Critical analysis of regulatory development plans Eligibility assessment & application to accelerated development pathways and authorization programs Support for request, preparation and during meetings with Competent Authorities at key steps of product development: Informational meetings, Scientific Advices, pre-IND meetings Author, review and submission of authorization / notifications regulatory dossiers in key global markets Learn more about our Regulatory Strategy & Submission service CMC, Nonclinical and Clinical development support Gap analysis of available CMC, nonclinical and clinical data in view of critical regulatory submissions Definition of individualized nonclinical and clinical development programs, protocols design Learn more about our CMC, Nonclinical and Clinical service EXPERTISE Regulatory Strategy & Submissions Access to Market Clinical Trial Operations Nonclinical and Clinical Chemistry, Manufacturing & Controls (CMC) Vigilance Publishing Due Diligence Patient Engagement GDPR and Data Protection WEBINAR Microbiome MICROBIOME: Navigating Regulatory and CMC Technical Development Roadmap Advances in genomic and big data analysis trends have significantly increased the interest of academia in the symbiotic relationship between… BLOG Microbiome The Microbiome Journey: Development of a Drug Product In a wide range of therapeutic areas, recent studies have highlighted the link between microbial imbalance (dysbiosis) and the development… EXPERTISE Regulatory Strategy & Submissions Design and implementation of global patient-centric regulatory strategies to ensure expedited product… Clinical Trial Operations Partner your way, we are your single contact for all activities towards… Nonclinical and Clinical Expect the unexpected Due to the increasing complexity of drug development and… GET IN TOUCH --- Afghanistan Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire, Sint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Cook Islands Costa Rica Croatia Cuba Curaçao Cyprus Czech Republic Côte d'Ivoire Democratic Republic of the Congo Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Holy See (Vatican City State) Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macau Macedonia, the former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Moldova Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island North Korea Northern Mariana Islands Norway Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Islands Poland Portugal Puerto Rico Qatar Rennes st Gregoire Romania Russian Federation Rwanda Réunion Saint Barthélémy Saint Helena, Ascension and Tristan da Cunha Saint Kitts and Nevis Saint Lucia Saint Martin (French part) Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten (Dutch part) Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands South Korea South Sudan Spain Sri Lanka State of Palestine Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syria São Tomé and Príncipe Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu USA Minor Outlying Islands Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Venezuela Vietnam Virgin Islands (British) Virgin Islands (USA) Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe Select your country...* --- Search Engine Conference Referral Social Media (LinkedIn, Twitter) Webinar Neighborhood Event Neighborhood Website How did you hear about us ?* --- Biologic Drugs Cell, Gene and Tissue Therapy Chemical Drugs Classical Medical Device Combination Product Digital Medical Device E-Health/M-Health IVDs & CDx Microbiome-based Products Vaccines Other Product type...* *I have read and agreed to the Terms of Use and the Privacy Policy. Yes, I would like to receive communications regarding VCLS services and events SEND VCLS INSIGHTS Blog Events Presentations Publications Whitepapers Webinars ABOUT Who We Are What We Do Team Jobs Life at VCLS Neighborhood VCLS © 1997 - 2021 - ALL RIGHTS RESERVED SITE MAP PRIVACY POLICY TERMS OF USE FOLLOW US ON SOCIAL MEDIA